Schmoll HJ - Search Results

1

A phase II study of high dose tamoxifen in progressive, metastatic renal cell carcinoma.

Stahl M, Wilke H, Schmoll HJ, Schöber C, Diedrich H, Casper J, Freund M, Poliwoda H. Stahl M, et al. Among authors: schmoll hj. Ann Oncol. 1992 Feb;3(2):167-8. doi: 10.1093/oxfordjournals.annonc.a058136. Ann Oncol. 1992. PMID: 1606089 Free article. Clinical Trial.

2

Epirubicin/dacarbazine rapidly alternated with ifosfamide in the treatment of metastatic soft tissue sarcomas.

Bokemeyer C, Harstrick A, Schmoll HJ, Köhne-Wömpner CH, Schöffski P, Poliwoda H. Bokemeyer C, et al. Among authors: schmoll hj. Ann Oncol. 1992 Jun;3(6):487-8. doi: 10.1093/oxfordjournals.annonc.a058243. Ann Oncol. 1992. PMID: 1498067

3

Phase II study of single-agent etoposide in patients with metastatic squamous-cell carcinoma of the esophagus.

Harstrick A, Bokemeyer C, Preusser P, Köhne-Wömpner CH, Meyer HJ, Stahl M, Knipp H, Schmoll HJ, Wilke H. Harstrick A, et al. Among authors: schmoll hj. Cancer Chemother Pharmacol. 1992;29(4):321-2. doi: 10.1007/BF00685952. Cancer Chemother Pharmacol. 1992. PMID: 1537080 Clinical Trial.

4

A 3-day schedule of 5-fluorouracil and folinic acid in metastatic progressive colorectal cancer and its impact in terms of palliation.

Schöber C, Köhne-Wömpner CH, Schmoll HJ, Stahl M, Wilke HJ, Poliwoda H. Schöber C, et al. Among authors: schmoll hj. Semin Oncol. 1992 Apr;19(2 Suppl 3):136-40. Semin Oncol. 1992. PMID: 1557639 Clinical Trial.

5

Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma.

Harstrick A, Schmoll HJ, Wilke H, Köhne-Wömpner CH, Stahl M, Schöber C, Casper J, Bruderek L, Schmoll E, Bokemeyer C, et al. Harstrick A, et al. Among authors: schmoll e, schmoll hj. J Clin Oncol. 1991 Sep;9(9):1549-55. doi: 10.1200/JCO.1991.9.9.1549. J Clin Oncol. 1991. PMID: 1651992

6

High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: a phase II study.

Harstrick A, Schmoll HJ, Wilke H, Schöber C, Stahl M, Wömpner CK, Bokemeyer C, Dölken G, Burk K, Poliwoda H. Harstrick A, et al. Among authors: schmoll hj. Ann Oncol. 1990 Sep;1(5):375-6. doi: 10.1093/oxfordjournals.annonc.a057778. Ann Oncol. 1990. PMID: 2261377 Free article. Clinical Trial.

7

Etoposide and split-dose cisplatin in small-cell lung cancer.

Wilke H, Achterrath W, Schmoll HJ, Gunzer U, Preusser P, Lenaz L. Wilke H, et al. Among authors: schmoll hj. Am J Clin Oncol. 1988 Oct;11(5):572-8. doi: 10.1097/00000421-198810000-00013. Am J Clin Oncol. 1988. PMID: 2845770

8

Antitumour effect and symptomatic control with interferon alpha 2b in patients with endocrine active tumours.

Schöber C, Schmoll E, Schmoll HJ, Poliwoda H, Schuppert F, Stahl M, Bokemeyer C, Wilke H, Weiss J. Schöber C, et al. Among authors: schmoll e, schmoll hj. Eur J Cancer. 1992;28A(10):1664-6. doi: 10.1016/0959-8049(92)90064-9. Eur J Cancer. 1992. PMID: 1382494

9

Prednimustine and mitoxantrone (PmM) in patients with low-grade malignant non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), and prolymphocytic leukemia (PLL).

Freund M, Wunsch-Zeddies S, Schäfers M, Wysk J, Seidel I, Hiddemann W, Hanauske AR, Link H, Schmoll HJ, Poliwoda H. Freund M, et al. Among authors: schmoll hj. Ann Hematol. 1992 Feb;64(2):83-7. doi: 10.1007/BF01715350. Ann Hematol. 1992. PMID: 1554799

10

The role of schedule dependency of 5-fluorouracil/leucovorin combinations in advanced colorectal cancer.

Schöber C, Bokemeyer C, Stahl M, Wilke HJ, Schmoll HJ, Poliwoda H. Schöber C, et al. Among authors: schmoll hj. Semin Oncol. 1992 Apr;19(2 Suppl 3):131-5. Semin Oncol. 1992. PMID: 1557638

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

441 results

Search Page

Filters